Round Type
Series B
Description
ImmunOs Therapeutics AG, a biopharmaceutical company, has raised $74 million in Series B financing.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as ImmunOs Therapeutics AG that raised within 45 days of this round, from Fundz verified event records.
- Camp4 Therapeutics Corp raised $100M (Series B) on July 20, 2022.
- i2O Therapeutics, Inc. raised $34M on July 18, 2022.
- BIOVIE INC. raised $6M on July 15, 2022.
- Renibus Therapeutics raised $15M on July 15, 2022.
- Faeth Therapeutics raised $47M (Funding Round) on June 30, 2022.
- Centaurus Therapeutics raised $2M on June 28, 2022.
Who to call at ImmunOs Therapeutics AG, and when
A new round usually means ImmunOs Therapeutics AG is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day ImmunOs Therapeutics AG raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ImmunOs Therapeutics AG, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ImmunOs Therapeutics AG. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ImmunOs Therapeutics AG raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansImmunOs Therapeutics AG raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.